基因证据解析慢性呼吸病与心血管病双向关系
研究采用双向孟德尔随机化,基于全基因组关联研究汇总数据,分析慢阻肺、哮喘与冠心病、心梗、心衰、房颤、缺血性卒中的遗传关系,并探讨吸烟和炎症标志物的共同作用。结果显示两者间遗传证据有限,仅哮喘与房颤风险存在名义显著关联,吸烟强烈增加所有疾病风险,IL6R与IL1RN对呼吸和心血管疾病呈现方向相反的作用。
要点
- 慢性呼吸病与心血管病之间缺乏明确的直接因果遗传证据。
- 哮喘与房颤风险存在名义显著遗传关联,校正吸烟后仍弱显著。
- 吸烟与炎症标志物是两类疾病共同的重要风险因素。
核心结论
- 慢性呼吸病与心血管病之间遗传证据有限,吸烟和炎症标志物共同影响两者。
- 两者共病病理生理可能不涉及直接因果,强调疾病复杂性。
研究设计与样本
- 采用双向孟德尔随机化分析,基于全基因组关联研究汇总数据。
- 纳入慢阻肺、哮喘、冠心病、心梗、心衰、房颤和缺血性卒中的汇总统计。
- 额外进行吸烟的单变量孟德尔随机化、校正吸烟的多变量孟德尔随机化及炎症标志物的顺式孟德尔随机化。
主要发现
- 哮喘与房颤风险存在名义显著遗传关联(ORIVW 1.036,95%CI 1.003至1.070)。
- 校正吸烟后哮喘与房颤关联仍弱显著(ORIVW 1.040,95%CI 1.008至1.074)。
- 遗传预测的终生吸烟强烈增加所有慢性呼吸病和心血管病风险。
- 遗传代理的IL6R浓度与哮喘风险增加相关,与冠心病、心梗、房颤和缺血性卒中风险降低相关。
- IL1RN降低慢阻肺风险但增加冠心病和心梗风险。
临床怎么用
- 临床应重视吸烟和炎症标志物在慢性呼吸病与心血管病共病中的共同作用。
- 对哮喘患者需关注房颤风险,尤其合并吸烟时。
- 针对IL6R和IL1RN等炎症通路的干预可能对呼吸和心血管疾病产生不同方向的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic respiratory diseases (CRDs) and cardiovascular diseases (CVDs) are leading global health burdens. Despite being common, CRD and CVD comorbidity is often underestimated due to overlapping symptoms and risk factors. Consequently, their relationship remains unclear. AIMS AND OBJECTIVES: To determine the bidirectional genetic relationship between CRD and CVD and explore smoking and inflammation as potentially shared joint risk factors. METHODS: We conducted bidirectional Mendelian randomisation (MR) to explore CRD-CVD relationships. Summary statistics from genome-wide association studies were retrieved for chronic obstructive pulmonary disease (COPD), asthma, coronary artery disease (CAD), myocardial infarction (MI), heart failure, atrial fibrillation (AF) and ischaemic stroke (IS). We performed additional analysis including univariable MR for smoking, multivariable MR adjusting for smoking and cis-MR to investigate the role of inflammatory markers. RESULTS: Our MR analysis found limited genetic evidence of relationships between CRD and CVD, and vice versa. However, a nominally significant genetic association was observed between asthma and an increased risk of AF (OR inverse-variance weighted (ORIVW) 1.036, 95% CI 1.003 to 1.070), remaining weakly significant after adjusting for smoking (ORIVW 1.040, 95% CI 1.008 to 1.074). Genetically predicted lifetime smoking strongly increased all CRD and CVD risk. Additionally, genetically proxied IL6R concentration associated with increased asthma risk and decreased CAD, MI, AF and IS risk, while IL1RN decreased COPD risk but increased CAD and MI risk. CONCLUSIONS: While we found limited genetic evidence linking CRD and CVD, smoking and inflammatory markers commonly affect both. These findings highlight the complexity of CRD-CVD comorbidities, whose pathophysiology likely does not involve direct causation of each other.
引用
- Naesilla N, Quint JK, Zuber V, et al. Understanding the bidirectional relationship between chronic respiratory disease and cardiovascular disease using genetic evidence. Thorax. 2026. PMID: 41241414. doi:10.1136/thorax-2024-222908
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。